EXPO

Business Context and Reporting Period

Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: October 3, 2003 (Third Quarter of Fiscal 2003)
Business Overview: Exponent is an engineering and scientific consulting firm providing solutions to complex problems across two primary segments: Environmental and Health, and Other Scientific and Engineering. The company operates on a 52-53 week fiscal calendar.

Key Financial Metrics

Margins (Q3 2003): Operating margin was approximately 13.0% ($4.6M / $35.7M). Net income margin was approximately 8.0%.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 15% ($4.7M) in Q3 2003 compared to Q3 2002, and 13% ($12.2M) for the nine-month period. Growth was driven by increased billable hours and higher billing rates in both segments.
• Profitability: Net income rose 35% in Q3 and 30% for the nine months ended October 3, 2003. Operating income increased 25% in Q3.
• Expense Trends:
  • Compensation: Increased 12% in Q3 due to salary increases, headcount growth, and higher accrued bonuses.
  • Reimbursable Expenses: Increased 49% in Q3, primarily due to technical supplies for defense technology projects (e.g., Army's Rapid Equipping Force).
  • General & Administrative: Increased 23% in Q3, partially offset by a non-recurring $310,000 credit in Q3 2002 from a favorable sales tax audit.
• Cash Flow: Net cash provided by operating activities increased to $8.2M for the nine months ended Oct 3, 2003, compared to $6.9M in the prior year. However, cash and cash equivalents decreased by $5.3M over the nine months due to significant investing activities.
• Investing Activities: Net cash used in investing activities was $12.9M for the nine months, driven by $11.0M in purchases of short-term investments.

Guidance, Outlook, and Risks

• Outlook: Management expects to utilize existing deferred tax assets. The company anticipates that its revolving mortgage note (currently $0 outstanding, $24.5M available) and operating cash flows will fund needs for the next 12 months, though future acquisitions may require additional capital.
• Key Risks:
  • Absence of Backlog: Backlog is small and not a reliable indicator of future revenue due to the nature of client-requested services.
  • Customer Concentration: Significant revenue is derived from the transportation industry and government sector; loss of a large client could be material.
  • Personnel: Success depends on attracting and retaining highly qualified technical staff in a competitive market.
  • Economic & Regulatory: Demand is cyclical and sensitive to economic slowdowns, tort reform, and changes in environmental regulations.
• Unusual Items: Q3 2002 included a $310,000 non-recurring credit from a sales tax audit. Q3 2002 also included a reserve on a note receivable affecting other income comparisons.

Investor Verification Checklist

• Revenue Quality: Verify the sustainability of the 15% revenue growth, specifically the reliance on defense technology projects which drove a 49% increase in reimbursable expenses.
• Cash Conversion: Note the $5.7M increase in accounts receivable during the nine-month period, which offset operating cash flow gains despite improved days sales outstanding (111 days vs 113 days).
• Compensation Leverage: Monitor compensation expenses as a percentage of revenue (57.7% in Q3 2003 vs 59.3% in Q3 2002) to ensure margin expansion continues as headcount grows.
• Stock Repurchases: Confirm the impact of $2.5M in common stock repurchases over the nine months on future liquidity and share count.
• Segment Performance: Review the "Other Scientific and Engineering" segment, which contributed the majority of revenue growth ($3.5M in Q3) compared to the Environmental and Health segment ($1.2M).